These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 10772385

  • 1. Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists.
    Lippert U, Möller A, Welker P, Artuc M, Henz BM.
    Exp Dermatol; 2000 Apr; 9(2):118-24. PubMed ID: 10772385
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines.
    Lippert U, Krüger-Krasagakes S, Möller A, Kiessling U, Czarnetzki BM.
    Exp Dermatol; 1995 Aug; 4(4 Pt 2):272-6. PubMed ID: 8528601
    [Abstract] [Full Text] [Related]

  • 3. Short-term and long-term cytokine release by mouse bone marrow mast cells and the differentiated KU-812 cell line are inhibited by brefeldin A.
    Zhu FG, Gomi K, Marshall JS.
    J Immunol; 1998 Sep 01; 161(5):2541-51. PubMed ID: 9725254
    [Abstract] [Full Text] [Related]

  • 4. The effect of H1 and H2 receptor blockers on immunological and nonspecific histamine release from isolated target cells.
    Hofman J, Siergiejko Z, Kuczewska B, Chyrek-Borowska S.
    Arch Immunol Ther Exp (Warsz); 1984 Sep 01; 32(5):599-604. PubMed ID: 6085468
    [Abstract] [Full Text] [Related]

  • 5. Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells.
    Kempuraj D, Huang M, Kandere-Grzybowska K, Basu S, Boucher W, Letourneau R, Athanassiou A, Theoharides TC.
    Int Arch Allergy Immunol; 2003 Nov 01; 132(3):231-9. PubMed ID: 14646384
    [Abstract] [Full Text] [Related]

  • 6. Production of interleukin-6 by human mast cells and basophilic cells.
    Krüger-Krasagakes S, Möller A, Kolde G, Lippert U, Weber M, Henz BM.
    J Invest Dermatol; 1996 Jan 01; 106(1):75-9. PubMed ID: 8592085
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of budesonide, desloratadine and dexamethasone on cytokine release from human mast cell line (HMC-1).
    Zhao Y, Leung PC, Woo KS, Chen GG, Wong YO, Liu SX, van Hasselt CA.
    Inflamm Res; 2004 Dec 01; 53(12):664-9. PubMed ID: 15654514
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine.
    Schroeder JT, Schleimer RP, Lichtenstein LM, Kreutner W.
    Clin Exp Allergy; 2001 Sep 01; 31(9):1369-77. PubMed ID: 11591186
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effects of budesonide, desloratadine and dexamethasone on interleukine-4 release and expression from human mast cell line].
    Zhao Y, van Hasselt CA, Woo KS, Wong YO, Liang CY, Leung PC.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Feb 01; 40(2):124-7. PubMed ID: 16429733
    [Abstract] [Full Text] [Related]

  • 12. Effects of antihistamines on isolated human lung mast cells, basophil leucocytes and erythrocytes.
    Lau HY, Pearce FL.
    Agents Actions; 1989 Apr 01; 27(1-2):83-5. PubMed ID: 2473642
    [Abstract] [Full Text] [Related]

  • 13. Modulation of in vitro cytokine release from human leukemic mast cells (HMC-1) by glucocorticoids.
    Lippert U, Welker P, Krüger-Krasagakes S, Möller A, Henz BM.
    Skin Pharmacol; 1996 Apr 01; 9(2):93-8. PubMed ID: 8722602
    [Abstract] [Full Text] [Related]

  • 14. The effect of mizolastine on expression of vascular endothelial cell growth factor, tumour necrosis factor-alpha and keratinocyte-derived chemokine in murine mast cells, compared with dexamethasone and loratadine.
    Xia Q, Yang S, Zhang SQ, Chen B, Wang DB, Zhu QX, Wang Y, Yan KL, He PP, Zhang XJ.
    Clin Exp Dermatol; 2005 Mar 01; 30(2):165-70. PubMed ID: 15725247
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of interleukin-4 and interleukin-13 release from immunologically activated human basophils due to the actions of anti-allergic drugs.
    Gibbs BF, Vollrath IB, Albrecht C, Amon U, Wolff HH.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 May 01; 357(5):573-8. PubMed ID: 9650812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FK506 inhibition of histamine release and cytokine production by mast cells and basophils.
    Sengoku T, Kishi S, Sakuma S, Ohkubo Y, Goto T.
    Int J Immunopharmacol; 2000 Mar 01; 22(3):189-201. PubMed ID: 10685002
    [Abstract] [Full Text] [Related]

  • 19. Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli.
    Vasiadi M, Kalogeromitros D, Kempuraj D, Clemons A, Zhang B, Chliva C, Makris M, Wolfberg A, House M, Theoharides TC.
    Int Arch Allergy Immunol; 2010 Mar 01; 151(1):38-45. PubMed ID: 19672095
    [Abstract] [Full Text] [Related]

  • 20. Dexamethasone inhibits maturation, cytokine production and Fc epsilon RI expression of human cord blood-derived mast cells.
    Smith SJ, Piliponsky AM, Rosenhead F, Elchalal U, Nagler A, Levi-Schaffer F.
    Clin Exp Allergy; 2002 Jun 01; 32(6):906-13. PubMed ID: 12047438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.